{
    "nct_id": "NCT03684811",
    "official_title": "A Phase 1b/2 Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation",
    "inclusion_criteria": "* Patients must have documented IDH1-R132 gene-mutated disease as evaluated by site\n* Glioma: Advanced glioma that has recurred or progressed following standard therapy, or that has not responded to standard therapy.\n* Hepatobiliary cancer that is relapsed/refractory or intolerant to approved standard-of-care therapy (including: hepatocellular carcinoma, bile duct carcinoma, intrahepatic cholangiocarcinoma or other hepatobiliary carcinomas)\n* Chondrosarcoma that is relapsed or refractory and either locally advanced or metastatic and not amenable to complete surgical excision\n* Intrahepatic cholangiocarcinoma that is advanced nonresectable or metastatic cholangiocarcinoma not eligible for curative resection or transplantation. Phase 1b/Safety Lead-in of Phase 2: relapsed or refractory disease. Combination Phase 2 (beyond Safety Lead-in): have received no more than 1 cycle of gemcitabine/cisplatin therapy\n* Other solid tumors that have relapsed or refractory to standard-of-care therapy with no other available therapeutic options\n* Good performance status\n* Good kidney and liver function\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior solid organ or hematopoietic cell transplant\n* Prior treatment with IDH1 inhibitor (single agent cohorts only)\n* Congestive heart failure (New York Heart Association Class III or IV) or unstable angina pectoris. Previous history of myocardial infarction within 1 year prior to study entry, uncontrolled hypertension or uncontrolled arrhythmias\n* Unstable or severe, uncontrolled medical condition (e.g., unstable cardiac function, unstable pulmonary condition, including pneumonitis and/or interstitial lung disease, and uncontrolled diabetes)\n* Active, uncontrolled bacterial, viral, or fungal infections, requiring systemic therapy\n* PD-1 only: active autoimmune disease",
    "miscellaneous_criteria": "Key"
}